SCHEMBL6986746

SCHEMBL6986746

CCN(CCN1CCCCCC1=O)CC(C)c1ccc(OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
POLB P06746 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980148 0.91 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1HTTKMT2AMEN1
SCHEMBL6981458 0.91 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1HTTKMT2AMEN1
SCHEMBL6984357 0.90 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1HTTKMT2AMEN1
SCHEMBL7135238 0.86 ADRA1B (0.44) ALDH1A1KMT2AMEN1RECQL
SCHEMBL6986741 0.83 MTNR1A (0.44) SMN1; SMN2ALDH1A1KMT2AMEN1NPC1
SCHEMBL6985464 0.81 LMNA (0.36) SMN1; SMN2ALDH1A1HTTKMT2APOLB
SCHEMBL6985684 0.81 ADRA1B (0.47) L3MBTL1
SCHEMBL6986641 0.78 EPHX2 (0.38) ALDH1A1L3MBTL1
SCHEMBL6985013 0.78 KMT2A (0.39) ALDH1A1KMT2AMEN1POLBL3MBTL1
SCHEMBL6987065 0.78 POLB (0.39) ALDH1A1KMT2APOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289965-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-03-12 EP disclosed
WO-2001090081-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 WO disclosed